SOFIA (Simple Online Family Intervention for ADHD) system is a co-commercialized initiative between MEMOTEXT Corporation, Mass General Hospital (MGH) and Partners Healthcare led by Dr. Joseph Biederman Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD. The team has created a web and SMS based program that helps address the taxing issue of medication adherence, support and education in children with attention deficit /hyperactivity disorder (ADHD). The collaboration advances work for patients and families with an evidence-based program developed by Dr. Biederman and his team at MGH. MEMOTEXT brings a dynamic digital model for interactive communications using adaptive logic to deploy dynamic/self-learning notifications to parents of children with ADHD about their child’s medication and treatment. Parents are encouraged to respond to messages to provide more information, which helps customize their personal experience further and make the program better by addressing specific needs. The SOFIA team will discuss co-commercialization and of working together to broaden the availability of the intervention for other stakeholders like pharmaceutical manufacturers, insurers and health systems. Studies have shown that at least 30% of families of children with ADHD do not renew their first prescription with the attendant adverse impact in quality of life, health economics and outcomes.
Amos Adler, MSc, President, MEMOTEXT
Joseph Biederman, MD, Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital